Statewide surveillance of carbapenemase-producing carbapenem-resistant Escherichia coli and Klebsiella species in Washington state, October 2012-December 2017.
Mimi R PrecitKelly KauberWilliam A GloverScott J WeissmanTashina RobinsonMichael TranMarisa D'AngeliPublished in: Infection control and hospital epidemiology (2021)
We report that blaKPC, the most prevalent carbapenemase in the United States, accounts for nearly half of carbapenemase cases in Washington state and that most KPC-cases are likely acquired through in-state health care.